Conference · Orlando, Florida
Drug Discovery for Neurodegeneration 2014
Medicine · Neurology · Physicians
Key numbers
- Editions on record
- 4first in 2012
About Drug Discovery for Neurodegeneration Conference
WHAT YOU WILL LEARN
1.
Challenges and opportunities in academic drug discovery
2. Fundamentals of medicinal chemistry relevant to drug discovery for neurodegenerative diseases
3. Newest trends in assay development and high throughput screening (HTS)
4. Go-no-go criteria for preclinical development, including pharmacokinetic behavior of candidate compounds, aqueous solubility, blood-brain barrier permeability, preliminary safety, and manufacturing issues
5. Study design considerations for animal model experiments
6. Biologics for challenging CNS targets and strategies to optimize brain delivery
7. Requirements for an Investigational New Drug (IND) application
8. Commercialization strategies for developing science into products
9. Best practices for working with tech transfer offices, managing intellectual property, and the role of funding organizations
10.
Funding & resources for preclinical therapeutics development for neurological disorders
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2015 | 1–3 Mar 2015 | Westgate Hotel San Diego, California | — | — |
| 2014 | 2–4 Feb 2014 | Miami Beach Resort & Spa Orlando, Florida | — | — |
| 2013 | 10–12 Feb 2013 | Hyatt at Fisherman's Wharf San Francisco, California | — | — |
| 2012 | 12–14 Feb 2012 | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.